Aurora Cannabis Inc. (ACB)
NASDAQ: ACB · Real-Time Price · USD
4.320
-0.110 (-2.48%)
At close: Jan 26, 2026, 4:00 PM EST
4.330
+0.010 (0.23%)
After-hours: Jan 26, 2026, 7:48 PM EST
Aurora Cannabis Revenue
Aurora Cannabis had revenue of 90.37M CAD in the quarter ending September 30, 2025, with 11.40% growth. This brings the company's revenue in the last twelve months to 367.13M, up 23.89% year-over-year. In the fiscal year ending March 31, 2025, Aurora Cannabis had annual revenue of 343.29M with 27.32% growth.
Revenue (ttm)
367.13M CAD
Revenue Growth
+23.89%
P/S Ratio
0.93
Revenue / Employee
342,148 CAD
Employees
1,073
Market Cap
245.98M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 343.29M | 73.66M | 27.32% |
| Mar 31, 2024 | 269.64M | 45.83M | 20.48% |
| Mar 31, 2023 | 223.80M | 2.47M | 1.11% |
| Jun 30, 2022 | 221.34M | -23.91M | -9.75% |
| Jun 30, 2021 | 245.25M | -23.45M | -8.73% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evolus | 285.82M |
| Akebia Therapeutics | 225.07M |
| Canopy Growth | 200.02M |
| Organigram Global | 186.08M |
| Kamada | 174.79M |
| Lifecore Biomedical | 128.87M |
| Anika Therapeutics | 112.81M |
| Eton Pharmaceuticals | 70.32M |
ACB News
- 6 days ago - Aurora Secures EU Community Plant Variety Rights for Two Proprietary Cannabis Varieties - PRNewsWire
- 12 days ago - 3 Marijuana Stocks For Investors To Make Money In 2026 - MarijuanaStocks
- 12 days ago - Aurora Achieves Significant Progress in Disease Resistance Research - PRNewsWire
- 17 days ago - Marijuana industry taking fight against Wall Street blockades straight to Trump - New York Post
- 20 days ago - Best Canadian Cannabis Stocks to Watch Entering 2026 - MarijuanaStocks
- 27 days ago - Trump Is Warming to Cannabis, but Investors Aren't Impressed - WSJ
- 4 weeks ago - Marijuana Stocks To Watch After The Holidays - MarijuanaStocks
- 5 weeks ago - Inside the dealmaking that pushed Trump to reclassify pot, expand access - CNBC